Literature DB >> 12828320

Changing epidemiology of community-onset methicillin-resistant Staphylococcus aureus bacteremia.

Leonard B Johnson1, Arti Bhan, Joan Pawlak, Odette Manzor, Louis D Saravolatz.   

Abstract

OBJECTIVES: To review cases of community-onset Staphylococcus aureus bacteremia and to evaluate whether the risk factors and epidemiology of methicillin-resistant S. aureus (MRSA) bacteremia have changed from early reports.
DESIGN: Retrospective case-comparison study of community-onset MRSA (n = 26) and methicillin-susceptible S. aureus (MSSA) (n = 26) bacteremias at our institution.
SETTING: A 600-bed urban academic medical center. PATIENTS: Twenty-six patients with community-onset MRSA bacteremia were compared with 26 patients with community-onset MSSA bacteremia. Molecular analysis was performed on S. aureus isolates from the 26 MRSA cases as well as from 13 cases of community-onset S. aureus bacteremia from 1980 and 9 cases of nosocomial S. aureus bacteremia from 2001.
RESULTS: The two groups were similar except that patients with MRSA bacteremia were more likely to have presented from a long-term-care facility (26.9% vs 4%; P = .05) and to have had multiple admissions within the preceding year (46% vs 15%; P = .03). Clamped homogeneous electric fields analysis of MRSA isolates from 1982 revealed predominantly that one clone was the epidemic strain, whereas there were 14 unique strains among current community-onset isolates. Among current nosocomial isolates, 3 patterns were identified, all of which were present in the community-onset cases.
CONCLUSIONS: Previously described risk factors for MRSA acquisition may not be helpful in predicting disease due to the polyclonal spread of MRSA in the community. Unlike early outbreaks of MRSA in patients presenting from the community, current acquisition appears to be polyclonal and is usually related to contact with the healthcare system.

Entities:  

Mesh:

Year:  2003        PMID: 12828320     DOI: 10.1086/502227

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  7 in total

1.  A model for surveillance of methicillin-resistant Staphylococcus aureus.

Authors:  Hannah Simons; Philip Alcabes
Journal:  Public Health Rep       Date:  2008 Jan-Feb       Impact factor: 2.792

2.  Update on management of skin and soft tissue infections in the emergency department.

Authors:  Michael S Pulia; Mary R Calderone; John R Meister; Jamie Santistevan; Larissa May
Journal:  Curr Infect Dis Rep       Date:  2014-09       Impact factor: 3.725

3.  Community-associated methicillin-resistant Staphylococcus aureus: reconsideration of therapeutic options.

Authors:  Matthew E Levison; Shirley Fung
Journal:  Curr Infect Dis Rep       Date:  2006-01       Impact factor: 3.725

4.  Epidemiology of European community-associated methicillin-resistant Staphylococcus aureus clonal complex 80 type IV strains isolated in Denmark from 1993 to 2004.

Authors:  A R Larsen; S Böcher; M Stegger; R Goering; L V Pallesen; R Skov
Journal:  J Clin Microbiol       Date:  2007-11-07       Impact factor: 5.948

Review 5.  Infection control strategies for preventing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in nursing homes for older people.

Authors:  Carmel Hughes; Michael Tunney; Marie C Bradley
Journal:  Cochrane Database Syst Rev       Date:  2013-11-19

6.  Feasibility of rapid polymerase chain reaction for detection of methicillin-resistant Staphylococcus aureus colonization among emergency department patients with abscesses.

Authors:  Michael S Pulia; Mary Calderone; Brad Hansen; Christine E Stake; Mark Cichon; Zhanhai Li; Nasia Safdar
Journal:  Open Access Emerg Med       Date:  2013-10-07

7.  Blurred Molecular Epidemiological Lines Between the Two Dominant Methicillin-Resistant Staphylococcus aureus Clones.

Authors:  Amy C Dupper; Mitchell J Sullivan; Kieran I Chacko; Aaron Mishkin; Brianne Ciferri; Ajay Kumaresh; Ana Berbel Caban; Irina Oussenko; Colleen Beckford; Nathalie E Zeitouni; Robert Sebra; Camille Hamula; Melissa Smith; Andrew Kasarskis; Gopi Patel; Russell B McBride; Harm van Bakel; Deena R Altman
Journal:  Open Forum Infect Dis       Date:  2019-06-27       Impact factor: 3.835

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.